Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes Among Socioeconomically Disadvantaged Communities

Launched by UNIVERSITY OF WISCONSIN, MADISON · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help prevent vision loss in people with diabetes, especially those who may face challenges accessing healthcare. Using a special program that combines artificial intelligence with regular doctor visits, called AI-BRIDGE, the researchers want to see if it can improve the number of people getting screened for eye problems caused by diabetes. The goal is to make sure people from all backgrounds can get the care they need and reduce differences in screening rates among different racial and ethnic groups.

To participate in this trial, you need to be over 21 years old, have been diagnosed with type 1 or type 2 diabetes, and have Medicaid insurance as your main coverage. Additionally, you should not have had any eye exams in the past year and currently do not have any known eye disease related to diabetes. If you join, you can expect to work with your regular healthcare provider to get screened for eye problems, and you'll be helping to improve healthcare for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Eligible patients include patients older than 21 years
• • Diagnosed with type 1 or 2 diabetes
• • No known diabetic eye disease
• • Medicaid as their primary insurance
• • Not had an eye exam in the prior year
• Exclusion Criteria:
• • -